DocuSign director Briggs Teresa exercised Options for 1,096 shares at $0 on Sep 1, 2026. The reported holdings after the transaction were 11,359 DocuSign shares and 3,288 derivative securities, while the transaction also included an award of 1,096 derivative securities, giving investors updated ownership information.
Key Highlights
- Briggs Teresa held 11,359 DocuSign shares following the transaction.
- The transaction included an award of 1,096 derivative securities.
- Briggs Teresa owned 3,288 derivative securities after the transaction.
DOCUSIGN, INC. (NASDAQ: DOCU) director Briggs Teresa exercised options for 1,096 shares at $0 on Sep 1, 2026.
$0 Option Exercise and Reported Holdings
Briggs Teresa held 11,359 DocuSign shares after completing the option exercise. The transaction was recorded alongside an award of 1,096 derivative securities. The company’s reported ownership information also showed Briggs Teresa with 3,288 derivative securities following the transaction. The exercise covered 1,096 DocuSign shares, with a stated price of $0 per share. These figures describe the holdings and securities recorded after the transaction. The transaction date was Sep 1, 2026.
FAQs
Q: What happened in the DocuSign option exercise?
A: DocuSign director Briggs Teresa exercised options for 1,096 shares at $0 on Sep 1, 2026. Her reported holdings then included 11,359 DocuSign shares.
Q: How many DocuSign shares did Briggs Teresa own afterward?
A: Briggs Teresa owned 11,359 DocuSign shares following the option exercise. The transaction involved options covering 1,096 shares at a stated price of $0.
Q: What derivative securities did the DocuSign director report?
A: Briggs Teresa was awarded 1,096 derivative securities and owned 3,288 derivative securities following the transaction. The reported transaction date was Sep 1, 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.